ArticleCrohn's & colitis 3602021

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission.

Anas Gremida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.